CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

Marc Scherlinger, Gaëtane Nocturne, Marko Radic, David Launay, Christophe Richez, Philippe Bousso, Édouard Forcade, Alain Meyer, Christian Jørgensen, Camille Bigenwald, Divi Cornec, Jean Sibilia, Jean Sibilia, Sylvain Choquet, Alexandre Bélot, Maurine Jouret, Samuel Bitoun, Zahir Amoura, Olivier Hermine, Olivier Hermine, Emmanuel Donnadieu, Emmanuel Donnadieu, Jérome Avouac, Marc Scherlinger, Gaëtane Nocturne, Maurine Jouret, Benjamin Terrier, Noémie Jourde‐Chiche, Gaetane NOCTURNE, Maurine JOURET, Benjamin TERRIER, Jean Sibilia, Alexandre Bélot, Olivier Hermine, Xavier MARIETTE, Laurent Peyrin‐Biroulet, Alexandre BELOT, Christian Jørgensen, Z. Amoura, Marie‐Elise Truchetet, Nathalie COSTEDOAT-CHALUMEAU, R. Seror, Alain Meyer, Divi Cornec, Justine Decroocq, Cristina Castilla‐Llorente, Claire Leibler, Philippe Bousso, G. Pugnet, Cristina CASTILLA-LLORENTE, J Zuber, Emmanuel Donnadieu, Samuel Bitoun, Sébastien Viel, Benjamin Fournier, Édouard Forcade, Samuel Bitoun, Sébastien Viel, Benjamin Fournier, Édouard Forcade